Literature DB >> 9333133

Quantification of biochemical markers of bone turnover by kinetic measures of bone formation and resorption in young healthy females.

C M Weaver1, M Peacock, B R Martin, G P McCabe, J Zhao, D L Smith, M E Wastney.   

Abstract

The quantification of biochemical markers of bone formation and resorption with kinetic measures of bone turnover is an essential step in their validation. Some biochemical markers have been validated by quantification against formation and resorption rates measured by calcium kinetics in adults with bone disease. However, none has been validated in healthy individuals who are undergoing skeletal growth and bone consolidation. Therefore, we have measured biochemical markers of bone formation (serum osteocalcin [OC], bone-specific alkaline phosphatase [BAP], and total alkaline phosphatase [ALP]) and resorption (serum tartrate resistant acid phosphatase [TRAP], urinary cross-linked N teleopeptides of type I collagen/creatinine [NTx/Cr], and hydroxyproline/creatinine [OHP/Cr]) in healthy females aged 11-32 years (n = 31) after an overnight fast to determine their relationship with bone formation (Vo+) and bone resorption (Vo-) as measured by calcium kinetics and balance. All biochemical markers were highly intercorrelated (r > 0.6, p < 0.001) as were Vo+ and Vo- (r = 0.91, p < 0.001). Highly significant correlations were present between bone formation measured by calcium kinetics (Vo+) and serum levels of bone biochemical markers (OC, r = 0.82, p = 0.001; ALP, r = 0.92, p = 0.001; and BAP, r = 0.90, p = 0.001) and between bone resorption measured by calcium kinetics (Vo-) and fasting serum levels and urine creatinine ratios of biochemical markers (TRAP, r = 0.77, p < 0.001; OHP/Cr, r = 0.79, p < 0.001; and NTx/Cr, r = 0.70, p < 0.001). Thus, biochemical markers of bone formation and resorption can be used to predict calcium kinetic rates during skeletal growth and the early years of formation of peak bone mass, ages at which strategies to build peak bone mass are important. Biochemical markers of formation and resorption are equally useful in predicting either the bone formation rate or the resorption rate.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9333133     DOI: 10.1359/jbmr.1997.12.10.1714

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  14 in total

1.  Bone remodeling markers: so easy to measure, so difficult to interpret.

Authors:  E Seeman; T V Nguyen
Journal:  Osteoporos Int       Date:  2015-11-11       Impact factor: 4.507

2.  Development of 41Ca-based pharmacokinetic model for the study of bone remodelling in humans.

Authors:  Manju Sharma; Zeljko Bajzer; Susanta K Hui
Journal:  Clin Pharmacokinet       Date:  2011-03       Impact factor: 6.447

3.  The association between serum osteocalcin levels and metabolic syndrome in Koreans.

Authors:  S J Bae; J W Choe; Y E Chung; B J Kim; S H Lee; H Y Kim; J M Koh; H K Kim; G S Kim
Journal:  Osteoporos Int       Date:  2010-12-09       Impact factor: 4.507

Review 4.  Osteoporosis in children and adolescents: etiology and management.

Authors:  Giampiero Igli Baroncelli; Silvano Bertelloni; Federica Sodini; Giuseppe Saggese
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

5.  Tetracycline and calcium kinetics are comparable for estimating bone resorption in rats.

Authors:  Yongdong Zhao; Jennifer M K Cheong; WangHee Lee; Meryl Wastney; Berdine R Martin; Connie M Weaver
Journal:  J Nutr       Date:  2010-07-28       Impact factor: 4.798

6.  Bone alterations in children with idiopathic hypercalciuria at the time of diagnosis.

Authors:  Maria-Goretti Moreira Guimarães Penido; Eleonora Moreira Lima; Viviane Santuari Parizotto Marino; Ana-Luiza Fialho Tupinambá; Anderson França; Marcelo Ferraz Oliveira Souto
Journal:  Pediatr Nephrol       Date:  2002-12-19       Impact factor: 3.714

7.  Growth and bone mineralization in patients with juvenile idiopathic arthritis.

Authors:  Ozgur Okumus; Muferet Erguven; Murat Deveci; Oznur Yilmaz; Mine Okumus
Journal:  Indian J Pediatr       Date:  2008-03       Impact factor: 1.967

8.  Interpretation of biomarkers of bone metabolism in children: impact of growth velocity and body size in healthy children and chronic disease.

Authors:  Shamir Tuchman; Meena Thayu; Justine Shults; Babette S Zemel; Jon M Burnham; Mary B Leonard
Journal:  J Pediatr       Date:  2008-06-16       Impact factor: 4.406

Review 9.  The impact of inflammation on bone mass in children.

Authors:  Wai W Cheung; Jian-Ying Zhan; Kyung Hoon Paik; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2011-01-01       Impact factor: 3.714

10.  High disease activity in ankylosing spondylitis is associated with increased serum sclerostin level and decreased wingless protein-3a signaling but is not linked with greater structural damage.

Authors:  Mariusz Korkosz; Jerzy Gąsowski; Piotr Leszczyński; Katarzyna Pawlak-Buś; Sławomir Jeka; Ewa Kucharska; Tomasz Grodzicki
Journal:  BMC Musculoskelet Disord       Date:  2013-03-19       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.